Page 5,759«..1020..5,7585,7595,7605,761..5,7705,780..»

American Stroke Association: Quick action key to stroke treatment

Posted: Published on February 5th, 2013

People having an ischemic stroke -- which accounts for nine in 10 strokes -- should receive clot-dissolving therapy, if appropriate, within 60 minutes of arriving at the hospital, according to new American Stroke Association guidelines published in the American Heart Association journal Stroke. Ischemic stroke is caused by a blood clot in the arteries leading to the brain. Calling 9-1-1 immediately after recognizing any of the warning signs of stroke -- and getting to a stroke center as fast as possible -- are still the most important steps for optimal stroke care. Rapid action a must During an acute stroke, physicians must evaluate and diagnose the patient as soon as possible to determine if the patient is eligible to receive the clot-dissolving drug recombinant tissue plasminogen activator (tPA), which must be given 4.5 hours within hours of symptom onset. The goal is to minimize "door to needle" time which provides the patient with the best opportunity for benefit from the treatment. "tPA can now be considered for a larger group of patients, including some those who present up to 4.5 hours from stroke onset," said Edward Jauch, M.D., lead author of the guidelines and director of the Division of Emergency … Continue reading →

Comments Off on American Stroke Association: Quick action key to stroke treatment

New technology advances cerebral palsy treatment

Posted: Published on February 5th, 2013

Just two years following a diagnosis of cerebral palsy at Seattle Childrens Hospital, Cody Marmon took his first independent steps. He was 3 years, one month and one day old. It was really exciting to watch, said Tina Marmon, Codys mother. Dr. David G. Embrey, the research program coordinator at MultiCare Good Samaritan Childrens Therapy Unit, witnessed Codys first steps along with Tina. About the same time, Embrey monitored Codys muscle movements and compared them with his brothers muscle movements, utilizing an innovative technology called Surface Electroymyography (SEMG). The technology, designed and manufactured by Noraxon, gives doctors an ability to place sensors on the top of the skin and record electrical signals from the brain that fire to make muscles move. The first time I went inside the body of a child with SEMG, I was absolutely astonished, Embrey said. The body was not functioning at all like my eyes were telling me. Ive now been able to take the technology and change what I do in treatment to become more effective. Embrey and his colleagues at Good Samaritan Childrens Therapy Unit recently were featured in Health Heroes on The Discovery Channel. The documentary explained how Embrey used SEMG to … Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on New technology advances cerebral palsy treatment

In combat vets and others, high rate of vision problems after traumatic brain injury

Posted: Published on February 5th, 2013

Feb. 4, 2013 Visual symptoms and abnormalities occur at high rates in people with traumatic brain injury (TBI) -- including Iraq and Afghanistan War veterans with blast-related TBI, reports a study, "Abnormal Fixation in Individuals with AMD when Viewing an Image of a Face," in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry. Vision problems are similar for military and civilian patients with TBI, and are common even after relatively mild brain injury, according to the report by Gregory L. Goodrich, PhD, of the VA Palo Alto (Calif.) Health Care System and colleagues. "Comprehensive eye examinations are recommended following even mild traumatic brain injury," comments Anthony Adams, OD, PhD, Editor-in-Chief of Optometry and Vision Science. High Rate of Vision Problems in after TBI The researchers analyzed rates and types of vision problems in 50 Iraq and Afghanistan War veterans with blast-related TBI. Blast-related TBI is a unique type of injury, with brain trauma caused by proximity to a blast or explosion, such as from an improvised explosive device. "There is understandably a great deal of interest in the impact of war injuries on veterans and the eyes are among the most impacted … Continue reading →

Posted in Brain Injury Treatment | Comments Off on In combat vets and others, high rate of vision problems after traumatic brain injury

Aqueduct: Dominguez moved to rehabilitation for work on brain injury

Posted: Published on February 5th, 2013

Email Barbara D. Livingston It is uncertain how long Ramon Dominguez will have to remain at his rehabilitation facility. Jockey Ramon Dominguez has begun a brain injury rehabilitation program at a hospital in White Plains, N.Y., as he continues to recover from a fractured skull he suffered in a spill at Aqueduct last month. Last Wednesday, Dominguez was transferred from New York-Presbyterian Hospital/Weill Cornell Medical Center in Manhattan to the Burke Rehabilitation Hospital. It is uncertain how long he will have to remain at Burke. "Ramon continues to do well and is improving every day," Sharon Dominguez, Ramon's wife, said in a press release issued through the New York Racing Association. "He was transferred to Burke on Wednesday, completed initial evaluations on Thursday, and started a brain injury rehabilitation program on Friday. "As Ramon takes the next steps in his treatment, he and I would like to thank everyone again for the continued support and prayers." Dominguez added. "Although his injury will take time to heal, Ramon is on the road to a full recovery." Dominguez, 36, was injured in a spill at Aqueduct on Jan. 18 when the horse he was riding, Convocation, clipped heels with a horse in … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Aqueduct: Dominguez moved to rehabilitation for work on brain injury

Ms.Pillai’s IMPLAUSIBLE stand

Posted: Published on February 5th, 2013

M. Haris Z Deen, Ph.D., MBA., BSc., LLB (Hons.) FRICS Naveen Pillai having failed in her earlier attempts in the United Nations Human Rights Council in March 2012 to humble and humiliate Sri Lanka on its Human Rights record, continues to rake muck in further attempts to save face at her previous failures. United Nations Human Rights Council session in progress Sri Lanka though bravely faced, confronted and responded effectively to all the charges levelled against her. Furthermore, Sri Lanka, in allowing foreign fact finding missions to the places ravaged by the civil conflict (which has been erroneously termed war) and to confront and question the very people, the Tamils, against whom Naveen claims atrocities have been committed have displayed complete transparency. So far none of these foreign agencies have been able to come up with any evidence to support the trumped up allegations. In fact, Sri Lanka in my view is the only country prepared to open its doors to such fact finding missions to travel freely to wherever they wished to go and speak to whomever they wished to gain evidence from, thus proving that she has no proverbial 'skeletons in her cupboards'. In fact in May 2012 … Continue reading →

Posted in MS Treatment | Comments Off on Ms.Pillai’s IMPLAUSIBLE stand

Medivation Elects Kathryn Falberg to Board of Directors

Posted: Published on February 5th, 2013

SAN FRANCISCO, CA--(Marketwire - Feb 4, 2013) - Medivation, Inc. ( NASDAQ : MDVN ) today announced that Kathryn E. Falberg has been elected to the Company's Board of Directors.Ms. Falberg will also serve as chair of the Audit Committee. "We are delighted to welcome an experienced pharmaceutical executive of Kate's caliber to Medivation's board," said David Hung, M.D., president and chief executive officer of Medivation, Inc. "As prior chief financial officer at Amgen and current chief financial officer at Jazz Pharmaceuticals, Kate brings to our board critical and highly relevant experience successfully leading pharmaceutical companies through periods of rapid growth.Her financial acumen and strategic business and commercial insight will be invaluable additions to our board at a critical time of growth and transformation for Medivation." "I am honored to join the Medivation Board of Directors at such an exciting time in the company's development," said Ms. Falberg."I admire Medivation's success in identifying and developing novel therapies that treat diseases with limited therapeutic options and look forward to providing strategic guidance to help further grow its business." Ms. Falberg currently serves as the executive vice president and chief financial officer of Jazz Pharmaceuticals plc. She also served as its senior … Continue reading →

Posted in MS Treatment | Comments Off on Medivation Elects Kathryn Falberg to Board of Directors

Creation of an International Gene Therapy Consortium

Posted: Published on February 5th, 2013

QUEBEC, Feb. 4, 2013 /CNW Telbec/ - In the latest issue of the journal Molecular Therapy, Professor Jacques P. Tremblay (president of the Association of Gene Therapy of Quebec and researcher in the Research center of the Centre Hospitalier Universitaire (CHU) of Quebec) launches a call - with 50 other world experts in gene therapy - for the creation of an International Gene Therapy Consortium for Monogenic Diseases. The bases of this consortium will be established during a workshop, which will be held during the congress of the American Society of Gene and Cell Therapy (ASGCT) in Salt Lake City in May 2013. Recent scientific progress in molecular biology and in genomics allowed during the recent years to identify the genes responsible for 10,000 hereditary diseases caused by a mutation in a single gene (for ex., Duchenne muscular dystrophy, Friedreich ataxia, haemophilia, etc.). On the other hand, recent progress of gene therapy resulted in treatments for some of these diseases previously considered incurable: hereditary immuno-deficiencies (the bubble children), a form of hereditary blindness (congenital amaurosis of Leber), etc. Also, for the first time, a gene-therapy treatment was approved for commercialization in Europe (for familial hyperchylomicronemia, a lipid disease). A Quebec … Continue reading →

Comments Off on Creation of an International Gene Therapy Consortium

Irish Stem Cell Foundation seeks to provide better legislation for stem cell research in Ireland – VIDEO

Posted: Published on February 5th, 2013

Published Monday, February 4, 2013, 8:08 AM Updated Monday, February 4, 2013, 8:08 AM As part of austerity measures, Ireland chose to abolish - or absorb into another position - the role of the chief science adviser Photo by Andrei Tchernov Austerity certainly had an impact on Ireland, and the sciences werent spared from the influence. As part of austerity measures, Ireland chose to abolish - or absorb into another position - the role of the chief science adviser, a position that had been around since 2005, in late 2012. According to Nature.com, the CSA helped to persuade the government to spare science, and urged it not to neglect longer-term investments in research capacity, in the wake of the 2008 Irish financial crisis. Since the abolishment of the role, many scientists and researchers in Ireland worry that their work may suffer as a result. One foundation, the Irish Stem Cell Foundation, is particularly against the move to abolish the role of the CSA. The Irish Stem Cell Foundation is an independent, non-profit medical research charity. Established in October 2009, it is composed of researchers, clinicians, patients advocates, patients, science communicators, bioethicists, lawyers, teachers, and students. Stem cells are of particular … Continue reading →

Posted in Stem Cell Research | Comments Off on Irish Stem Cell Foundation seeks to provide better legislation for stem cell research in Ireland – VIDEO

Two life sciences firms to join forces, create larger Stem Cell Therapeutics

Posted: Published on February 5th, 2013

TORONTO - Two small Canadian life science research companies are planning to combine forces to focus on treating cancer with stem cell technologies Stem Cell Therapeutics Corp. (TSXV:SSS) will acquire Trillium Therapeutics Inc., both headquartered in Toronto, but all of Trillium's executives and staff will remain with the new company being created and Trillium's chief executive will be its CEO. Under terms of the deal, Trillium's security holders are to receive $1.2 million in cash and shares in the new company also to be called Stem Cell Therapeutics valued at $1.65 million. Trillium CEO Niclas Stiernholm, who is also a director of Stem Cell Therapeutics Corp., will be chief executive of the combined company. Trillium is a private company that was created to advance work done by six Ontario research institutions. It currently has two oncology research programs at the preclinical stage. Stem Cell Therapeutics if focused on acquiring technologies and capital to advance treatments towards commercialization. See the original post here: Two life sciences firms to join forces, create larger Stem Cell Therapeutics … Continue reading →

Posted in Stem Cell Research | Comments Off on Two life sciences firms to join forces, create larger Stem Cell Therapeutics

A Single Type Of Stem Cell Give Rise To Three Types Of Taste Cells

Posted: Published on February 5th, 2013

February 4, 2013 Brett Smith for redOrbit.com Your Universe Online As stem cell research progresses, scientists are becoming more and more specialized in studying the types of cells and tissues that they generate. In pursuing the mechanisms that drive stem cell specialization, scientists at the Monell Chemical Senses Center in Philadelphia have identified certain genetic characteristics of taste stem cells and their location on the tongue, according to their report in the journal Stem Cells. Cancer patients who have taste loss following radiation to the head and neck and elderly individuals with diminished taste function are just two populations who could benefit from the ability to activate adult taste stem cells, said study co-author Dr. Robert Margolskee, a molecular neurobiologist at Monell. Taste stems cells differentiate into three different types of taste cells, all of which are found within the tiny taste buds that dot the tongue. Two types of taste cells, also referred to as gustatory cells, contain chemoreceptors that convey the various kinds of taste, including bitter, sweet, sour and umami. The third type of taste cell performs more of a structural function. One of the remarkable properties of taste cells is their ability to regenerate. All three … Continue reading →

Posted in Stem Cell Research | Comments Off on A Single Type Of Stem Cell Give Rise To Three Types Of Taste Cells

Page 5,759«..1020..5,7585,7595,7605,761..5,7705,780..»